FDA Okays OxyContin for Some Pediatric PatientsFDA Okays OxyContin for Some Pediatric Patients

The opioid is indicated for children aged 11 to 16 years with pain severe enough to require daily, around-the-clock, long-term opioid treatment for which alternative treatment options are inadequate. FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news